China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prognostic impact of thymosin in sepsis patients with immunosuppression: a clinical study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132174
Registration Time: 2026/09/10
Type: Observational study
Primary Sponsor: Jiangdu People’s Hospital Affiliated to Yangzhou University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342751
Published by HT Digital Content Services with permission from Health Daily Digest....